Breast cancer is the most diagnosed cancer in women worldwide and the leading cause of most cancer-related deaths,posing a serious threat to women′s health worldwide.At present,although the prognosis of some patients with breast cancer has improved,the emergence of drug resistance and the metastasis and recurrence of breast cancer are still the main reasons for poor prognosis.CD36 is a multiligand transmembrane glycoprotein expressed on various cell types.In recent years,studies have confirmed that CD36 can reshape the lipid metabolism of cancer cells;promote the differentiation of tumor-related macrophages into M2 type and recruitment into tumor tissues;regulate the function of Treg cells,CD8+T cells,DCs,and other immune cells,and thus promote tumor development.In addition,CD36 is also associated with breast cancer stem cells,metastasis-initiating cells,and breast drug resistant cells.Therefore,CD36 could be an important potential therapeutic target for breast cancer.

Objective　To investigate the clinical data of pediatric community-acquired necrotizing pneumonia (NP) in 2023, summarizing its clinical characteristics and pathogen profile distribution. Methods The clinical data of hospitalized children with NP in 2023 at Henan Children's Hospital were retrospectively analyzed. Comparisons were made with those in the non-NP group to summarize the clinical symptoms, pathogenetic features, laboratory indices and imaging changes, treatment, and prognosis. Results Among the 133 NP cases, there were 64 males and 69 females, with a median age of 7 years. In the non-NP group, there were 61 cases, including 38 males and 23 females, with a median age of 6. The NP group showed significantly higher proportions of chest pain, dyspnea, poor mental response, refusal of food/dehydration signs, and extrapulmonary complications compared to the non-NP group (P<0.05). The hospitalization duration of NP children was 18 days, with a fever duration of 12 days. They had a peripheral blood leukocyte count of 11.44×109/L, C-reactive protein of 37.44 mg/L, procalcitonin of 0.207 ng/mL, blood sedimentation of 40 mm/h, D-dimer of 1.99 μg/mL, lactate dehydrogenase of 455 U/L, and serum ferritin of 233.8 μg/L, all significantly higher compared to the non-NP group (P<0.05). Enhanced chest CT in the NP group revealed necrotic foci on the (17.47±6.56) day of the disease, with some cases complicated by pleural effusion, pleural thickening, bronchial stenosis or dilatation, pulmonary atelectasis, pulmonary embolism, etc., accompanied by different degrees of impaired lung function. Bronchoscopy revealed mucosal congestion and edema, with some showing mucosal erosion and necrosis, phlegm thrombus obstruction, and rice soup-like secretions. Pathogens were detected in 129 (97.0%) children in the NP group, with the top five infectious agents being Mycoplasma pneumoniae, Streptococcus pneumoniae, adenovirus, rhinovirus, and influenza B virus. There were 76 cases (57.1%) of single pathogen infection, and 53 cases (39.8%) of mixed infection. The mixed infection group had higher peripheral blood leukocyte counts, poor mental response, refusal of food/dehydration signs, extrapulmonary complications, and application of gamma globulin compared to the non-mixed infection group (P<0.05). The prognosis was generally good after anti-infective and symptomatic supportive treatment, with some cases having residual respiratory sequelae. Conclusions Children with NP have a long course of disease, high inflammatory indexes, and are prone to intrapulmonary and extrapulmonary complications and lung function impairment. Chest CT enhancement scanning and bronchoscopy are helpful for early recognition of NP. The pathogen of NP infections in 2023 is dominated by drug-resistant Mycoplasma pneumoniae, with some children experiencing multi-pathogen mixed infections. The prognosis is generally good with aggressive treatment.

Objective To explore the relationship of changes in bone mineral density and bone me-tabolism indicators with osteoporosis in elderly patients with hemiplegia after cerebral infarction.Methods A total of 197 elderly patients suffering post-stroke hemiplegia admitted to our hospital were enrolled between February 2018 and February 2021.Their bone mineral density and bone metabolism indicators were analyzed based on gender,disease course and hemiplegia severity.According to disease severity,they were divided into mild group(112 cases),moderate group(62 cases)and severe group(32 cases).Results Among the 197 elderly patients,83(42.13％)had osteoporosis.The males had significantly higher bone mineral density of proximal femur and levels of bone alkaline phosphatase(BALP)and osteocalcin,and lower levels of serum type Ⅰ collagen(CICP)and C-terminal telopeptides of type Ⅰ collagen(CTXI)than the females(P＜0.01,P＜0.05).Compared with the patients with hemiplegia course for 3-6 months,bone mineral density values of greater trochanter and total hip,and levels of BALP and osteocalcin were obviously de-creased,while levels of CICP and CTXI were notably increased in those with the course of 7-12 months and 13-24 months(P＜0.05).Compared with the mild group,bone mineral density val-ues of greater trochanter and total hip,and levels of BALP and osteocalcin were significantly de-creased,while levels of CICP and CTXI were significantly increased in moderate group and severe group(P＜0.05).Compared with the moderate group,bone mineral density values of greater tro-chanter,intertrochanteric site and total hip were significantly decreased in the severe group(P＜0.05).The bone mineral density of above parts was negatively correlated with CICP levels(r=-0.458,r=-0.403,r=-0.355,r=-0.482,P＜0.01)and CTXI levels(r=-0.305,r=-0.291,r=-0.273,r=-0.384,P＜0.05,P＜0.01),while positively correlated with BGP level(r=0.476,r=0.428,r=0.386,r=0.518,P＜0.01).Conclusion The incidence of osteoporosis is quite higher in the elderly patients with post-stroke hemiplegia.There exist bone mineral density decline and abnormal bone metabolism,and their changes are related to gender,course and severi-ty of hemiplegia.

ObjectiveTo study the effects and molecular mechanisms of Shuanglong Pill on angiogenesis of ischemic myocardium. Methods63 Wistar rats were ligated left anterior descending branch to be made into models of acute myocardial infarction(AMI).All rats were randomly divided into large-dosage group of Shuanglong Pill(LDG),small-dosage group of Shuanglong Pill(SDG),The control of acute MI(MIC).Other 11 rats were set as normal control(NC).Rats in every group had been treated half for 2 weeks and half for 4 weeks. New vessels' quantity in ischemic myocardium of acute MI rats were detected by immunohistochemistry double steps assay;the expressions of vessel endothelial growth factor(VEGF) and basic fibroblast growth factor(bFGF) on ischemic myocardium were detected by immunohistochemistry SP assay;the expressions of VEGF mRNA and bFGF mRNA on ischemic myocardium were detected by reverse transcription polymerase chain reaction(RT-PCR) assay.ResultsThere were more new capillaries on ischemic myocardium of LDG, SDG compared with that in MIC at every stage,moreover,there was significantly increase at the end of 4 weeks compared with that at 2 weeks.At the end of 2 weeks, the expression of VEGF in LDG were significantly elevated compared with that in MIC; and the expression of bFGF in LDG were significantly elevated compared with that in SDG and MIC.Whereas the expression of VEGF in LDG were significantly decreased at the end of 4 weeks compared with 2 weeks. There were significant differences of above comparison (P<0.05-0.01).At every stage the expression of VEGF mRNA in LDG, SDG were significantly elevated compared with that in MIC; but its expression was significantly decreased at the end of 4 weeks compared with that 2 weeks. The expression of bFGF mRNA was significantly elevated in LDC at the end of 2 weeks compared with that in other groups.ConclusionsShuanglong Pill could promote angiogenesis in ischemic myocardium,application of large dose of Shuanglong Pill could significantly upregulate the expression of VEGF, bFGF, VEGF mRNA and bFGF mRNA.